Value-Based Care in the Worldwide Battle Against Cancer

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2017 Mar 31

PMID 28357171

Citations 10

Authors

Niloufer J Johansen

Christobel M Saunders

Affiliations

Soon will be listed here.

Abstract

Globally, an increasing and aging population is contributing to the prevalence of cancer. To be effective, cancer care needs to involve the coordination of multidisciplinary specialties, and also needs to be affordable, accessible, and capable of producing optimal patient outcomes. Porter and Teisberg (2006) have postulated that shifting current healthcare strategies from volume-based to patient-centric care redirects economic competition to providing treatments which promote the best patient outcomes while driving down costs. Therefore, the value in value-based healthcare (VBH) is defined as patient outcome per currency spent on providing care. Based on the experiences of healthcare organizations currently transitioning to the value-based system, this review details actionable guidelines to transition current cancer care practices to the value-based system in four main steps: by defining universal clinical and patient-reported measures, creating cancer-specific units that provide the full care cycle, establishing a data capture model to routinely determine the value of the care delivered, and continually improving treatment strategies through research. As healthcare providers in more developed countries move to value-based care, those located in less developed countries should also be assisted in their transition to relieve the cancer burden globally.

Citing Articles

Now, more than ever, timing is right for oncology nurses to champion, co-design, and promote value-based and strengths-based cancer care!.

Loiselle C Can Oncol Nurs J. 2023; 33(2):180-181.

PMID: 37152820 PMC: 10155767.

Choosing Wisely-Barriers and Solutions to Implementation in Low and Middle-Income Countries.

Rubagumya F, Sengar M, Ka S, Hammad N, Booth C, Karim S Curr Oncol. 2022; 29(7):5091-5096.

PMID: 35877263 PMC: 9320636. DOI: 10.3390/curroncol29070403.

Length of hospital stay after uncomplicated esophagectomy. Hospital variation shows room for nationwide improvement.

Voeten D, van der Werf L, van Sandick J, van Hillegersberg R, van Berge Henegouwen M Surg Endosc. 2020; 35(11):6344-6357.

PMID: 33104919 PMC: 8523439. DOI: 10.1007/s00464-020-08103-4.

A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey.

Cherkaoui Z, Gonzalez C, Wakabayashi T, Delattre B, Leost E, Serra S Ann Surg Oncol. 2020; 28(2):1069-1078.

PMID: 32514806 DOI: 10.1245/s10434-020-08679-0.

CMS Hospital Compare System of Star Ratings and Surgical Outcomes Among Patients Undergoing Surgery for Cancer: Do the Ratings Matter?.

Mehta R, Paredes A, Tsilimigras D, Farooq A, Sahara K, Merath K Ann Surg Oncol. 2019; 27(9):3138-3146.

PMID: 31792714 DOI: 10.1245/s10434-019-08088-y.

References

McAlearney A, Reiter K, Weiner B, Minasian L, Song P . Challenges and facilitators of community clinical oncology program participation: a qualitative study. J Healthc Manag. 2013; 58(1):29-44. PMC: 3763953. View

Mayer D, Nasso S, Earp J . Defining cancer survivors, their needs, and perspectives on survivorship health care in the USA. Lancet Oncol. 2017; 18(1):e11-e18. DOI: 10.1016/S1470-2045(16)30573-3. View

Pollock R . Value-based health care: the MD Anderson experience. Ann Surg. 2008; 248(4):510-6. DOI: 10.1097/SLA.0b013e31818a6162. View

Prades J, Remue E, Van Hoof E, Borras J . Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health Policy. 2014; 119(4):464-74. DOI: 10.1016/j.healthpol.2014.09.006. View

Bietz M, Bloss C, Calvert S, Godino J, Gregory J, Claffey M . Opportunities and challenges in the use of personal health data for health research. J Am Med Inform Assoc. 2015; 23(e1):e42-8. PMC: 4954630. DOI: 10.1093/jamia/ocv118. View

Feeley T, Fly H, Albright H, Walters R, Burke T . A method for defining value in healthcare using cancer care as a model. J Healthc Manag. 2010; 55(6):399-411. View

Mak K, van Bommel A, Stowell C, Abrahm J, Baker M, Baldotto C . Defining a standard set of patient-centred outcomes for lung cancer. Eur Respir J. 2016; 48(3):852-60. PMC: 5007221. DOI: 10.1183/13993003.02049-2015. View

Morgans A, van Bommel A, Stowell C, Abrahm J, Basch E, Bekelman J . Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach. Eur Urol. 2015; 68(5):891-8. DOI: 10.1016/j.eururo.2015.06.007. View

Lyman G . Comparative effectiveness research in oncology. Oncologist. 2013; 18(6):752-9. PMC: 4063403. DOI: 10.1634/theoncologist.2012-0445. View

10.

Folbre N . Economics. When a commodity is not exactly a commodity. Science. 2008; 319(5871):1769-70. DOI: 10.1126/science.1153904. View

11.

Pillay B, Wootten A, Crowe H, Corcoran N, Tran B, Bowden P . The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature. Cancer Treat Rev. 2015; 42:56-72. DOI: 10.1016/j.ctrv.2015.11.007. View

12.

Parmar M, Barthel F, Sydes M, Langley R, Kaplan R, Eisenhauer E . Speeding up the evaluation of new agents in cancer. J Natl Cancer Inst. 2008; 100(17):1204-14. PMC: 2528020. DOI: 10.1093/jnci/djn267. View

13.

Sullivan R, Alatise O, Anderson B, Audisio R, Autier P, Aggarwal A . Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015; 16(11):1193-224. DOI: 10.1016/S1470-2045(15)00223-5. View

14.

McWilliams J, Hatfield L, Chernew M, Landon B, Schwartz A . Early Performance of Accountable Care Organizations in Medicare. N Engl J Med. 2016; 374(24):2357-66. PMC: 4963149. DOI: 10.1056/NEJMsa1600142. View

15.

Ong W, Schouwenburg M, van Bommel A, Stowell C, Allison K, Benn K . A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) Initiative. JAMA Oncol. 2016; 3(5):677-685. DOI: 10.1001/jamaoncol.2016.4851. View

16.

Fitzmaurice C, Allen C, Barber R, Barregard L, Bhutta Z, Brenner H . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2016; 3(4):524-548. PMC: 6103527. DOI: 10.1001/jamaoncol.2016.5688. View

17.

. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1459-1544. PMC: 5388903. DOI: 10.1016/S0140-6736(16)31012-1. View

18.

Wang C, Cheng S, Wu J, Lin Y, Kao W, Lin C . Association of a Bundled-Payment Program With Cost and Outcomes in Full-Cycle Breast Cancer Care. JAMA Oncol. 2016; 3(3):327-334. DOI: 10.1001/jamaoncol.2016.4549. View

19.

Slavova-Azmanova N, Johnson C, Platell C, Bydder S, Saunders C . Peer review of cancer multidisciplinary teams: is it acceptable in Australia?. Med J Aust. 2015; 202(3):144-7. DOI: 10.5694/mja14.00768. View

20.

Johns L, Coleman D, Swerdlow A, Moss S . Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study. Br J Cancer. 2016; 116(2):246-252. PMC: 5243996. DOI: 10.1038/bjc.2016.415. View